Search Results 71-80 of 19309 for prostate cancer
Prostate cancer that's detected early — when it's still confined to the prostate gland — has a better chance to be successfully treated, so it's important that ...
Prostate cancer is the second most common cancer in men worldwide. It's important that men are screened for the disease to catch it early, and a study in ...
The objective of this pilot stdy is to plan, develop and establish the acceptance and usability of a Point of Prostate Cancer Diagnosis (PPCD) iCCaRE Virtual ...
This is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate cancer (mCRPC).
... prostate cancers and the surveillance of less aggressive prostate cancers ... Prostate cancer is the most common cancer in men. Over the last several ...
Prostate cancer is the second most common cancer — second to skin cancer — among men in the U.S. One in 9 men will be diagnosed with prostate cancer in his ...
... prostate cancer also may be present in some cases of low-risk prostate cancers. The study found the needle biopsy procedure may miss higher-risk cancer that ...
The purpose of this study is to compare the effects (good and bad) on patients with prostate cancer by comparing the standard dose of radiation therapy (44 ...
Frank also describes treatment options for patients with prostate cancer. http://www.youtube.com/watch?v=HH-4poCVHOk. Prostate Cancer Surgical Treatment. Mayo ...
"Men with castration-resistant prostate cancer have abysmal survival rates, typically living an average of two years once hormone therapies fail," says Manish ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.